This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the acute leukaemias. French–American–British (FAB) cooperative group Br J Haematol 1976 33: 451–458
Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS . Fusion between transcription factor CBFβ/PEPB2β and a myosin heavy chain in acute myeloid leukemia? Science 1993 261: 1041–1044
Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Carrol AJ, Behm F, Hulshof MG, Motroni TA, Okuda T, Liu P, Collins FS, Downing JR . Heterogeneity in CBFβ-MYH11 fusion messages encoded by the inv(16)(p13;q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia Blood 1995 85: 3695–3370
Van der Reijden BA, Lombardo M, Dauwerse HS, Giles RH, Mulhematter D, Bellomo MJ, Wessels HW, Beverstock GC, Van Ommen GJB, Hagemeijer A, Breuning MH . RT-PCR diagnosis of patients with acute non-lymphocytic leukemia and inv(16)(p13;q22) and identification of new alternative splicing in CBFβ-MYH11 transcripts Blood 1995 86: 277–282
Costello R, Sainty D, Lecine P, Cusenier A, Mozziconacci MJ, Arnoulet C, Maraninchi D, Gastaut JA, Imbert J, Lafage-Pochitaloff M, Gabert J . Detection of CBFβ-MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics Leukemia 1997 11: 644–650
Van Dongen JJM, Macintyre EA, Gabert JA, Dealabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger, Parreira A, Gameira P, Gonzalez Diaz M, Malec M, Langerak AW, San Miguel JF, Biondi A . Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease Leukemia 1999 13: 1901–1928
Dissing M, Lebeau MM, Pedersen-Bjergaard J . Inversion of chromosome 16 and uncommon rearrangements of the CBFβ and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? J Clin Oncol 1998 16: 1890–1896
Preudhomme C, Wattel E, Lai JL, Henic N, Meyer L, Noel MP, Cosson A, Jouet JP, Fenaux P . Good predictive value of combined cytogenetic and molecular follow-up chronic myelogenous leukemia after non-T cell-depleted allogenic bone marrow transplantation: a report on 38 consecutive cases Leuk Lymphoma 1995 18: 265–271
Acknowledgements
We are indebted to D Talandier, R Coudenis, M Crepin and the Institut Fédératif de Recherche No. 22 (Lille, France) for their excellent technical assistance and support in molecular biology. This work was supported by CHU of Lille (PHRC 1997) The Ligue nationale contre le cancer (Comité du Nord et de l'Aisne) and the Fondation of France (Comité des leucémies)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grardel, N., Roumier, C., Soenen, V. et al. Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFβ-MYH11 transcript: report of two new cases. Leukemia 16, 150–151 (2002). https://doi.org/10.1038/sj.leu.2402332
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402332